Waning Immune Humoral Response to BNT162b2 Covid-19 Vaccine over 6 Months.

Einav G LevinYaniv LustigCarmit CohenRonen FlussVictoria IndenbaumSharon AmitRam DoolmanKeren AsrafElla MendelsonArnona ZivCarmit RubinLaurence FreedmanYitshak KreissGili Regev-Yochay

Published in: The New England journal of medicine (2021)

Six months after receipt of the second dose of the BNT162b2 vaccine, humoral response was substantially decreased, especially among men, among persons 65 years of age or older, and among persons with immunosuppression.

Keyphrases

immune response
coronavirus disease
middle aged
sars cov
respiratory syndrome coronavirus